Literature DB >> 20969485

What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children?

Ebe D'Adamo1, Cosimo Giannini, Valentina Chiavaroli, Tommaso de Giorgis, Alberto Verrotti, Francesco Chiarelli, Angelika Mohn.   

Abstract

The endogenous secretory receptor for advanced glycation end products (esRAGE) and soluble RAGE (sRAGE) have been shown in human plasma and have emerged as reliable biomarkers of several pathological conditions, including insulin resistance and liver injury. We examined esRAGE and sRAGE levels in obese prepubertal children with and without liver steatosis. esRAGE and sRAGE levels were significantly lower in obese prepubertal children affected by liver steatosis and were independently related to liver steatosis. These findings suggest that AGE-RAGE pathway plays an independent role in the development of liver injury already present in this age group.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20969485     DOI： 10.1089/ars.2010.3719

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN： 1523-0864            Impact factor:   8.401


  10 in total

Review 1.  Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

Review 2.  Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?

Authors:  Kailash Prasad; Amal S Khan; Kalpana K Bhanumathy
Journal:  Int J Angiol       Date:  2022-02-12

3.  Soluble receptor for advanced glycation end products and risk of liver cancer.

Authors:  Kristin A Moy; Li Jiao; Neal D Freedman; Stephanie J Weinstein; Rashmi Sinha; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

4.  Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Authors:  Mohamed Rowisha; Manal El-Batch; Thanaa El Shikh; Salwa El Melegy; Hany Aly
Journal:  Pediatr Res       Date:  2016-03-18       Impact factor: 3.756

Review 5.  Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children.

Authors:  Anshu Gupta; Jaime Uribarri
Journal:  Horm Res Paediatr       Date:  2016-03-19       Impact factor: 2.852

6.  Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population.

Authors:  Han Ma; Chengfu Xu; Lei Xu; Chaohui Yu; Min Miao; Youming Li
Journal:  BMC Gastroenterol       Date:  2013-01-07       Impact factor: 3.067

7.  Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age.

Authors:  Valentina Chiavaroli; Ebe D'Adamo; Cosimo Giannini; Tommaso de Giorgis; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

8.  Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease.

Authors:  Dana Ivancovsky-Wajcman; Shira Zelber-Sagi; Naomi Fliss Isakov; Muriel Webb; Meir Zemel; Oren Shibolet; Revital Kariv
Journal:  Clin Transl Gastroenterol       Date:  2019-05-22       Impact factor: 4.488

Review 9.  RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease.

Authors:  Kamyar Asadipooya; Kamran B Lankarani; Rishi Raj; Mohammadreza Kalantarhormozi
Journal:  Int J Endocrinol       Date:  2019-09-18       Impact factor: 3.257

10.  Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

Authors:  Christos Spanos; Elaina M Maldonado; Ciarán P Fisher; Petchpailin Leenutaphong; Ernesto Oviedo-Orta; David Windridge; Francisco J Salguero; Alexandra Bermúdez-Fajardo; Mark E Weeks; Caroline Evans; Bernard M Corfe; Naila Rabbani; Paul J Thornalley; Michael H Miller; Huan Wang; John F Dillon; Alberto Quaglia; Anil Dhawan; Emer Fitzpatrick; J Bernadette Moore
Journal:  Proteome Sci       Date:  2018-02-14       Impact factor: 2.480
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.